Načítá se...
Biomarkers in the Assessment of Therapies for Familial Amyloidotic Polyneuropathy
The identification of specific biomarkers provides opportunities to develop early diagnostic parameters, monitor disease progression, and test drug efficiency in clinical trials. We previously demonstrated that in familial amyloidotic polyneuropathy (FAP) related to the abnormal extracellular tissue...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
ScholarOne
2007
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2017105/ https://ncbi.nlm.nih.gov/pubmed/17932549 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2119/2007-00068.Macedo |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|